Skip to main content
Jithin Yohannan, MD, Ophthalmology, Baltimore, MD

JithinYohannanMDMPH

Ophthalmology Baltimore, MD

Anterior Segment Related, Cataract Related, Glaucoma Related

Assistant Professor

Dr. Yohannan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Yohannan's full profile

Already have an account?

  • Office

    1800 Orleans St
    Baltimore, MD 21287
    Phone+1 410-955-5080
    Fax+1 410-614-8496

Summary

  • Jithin Yohannan, M.D., M.P.H. is an Assistant Professor of Ophthalmology at the Wilmer Eye Institute, Johns Hopkins University School of Medicine. His practice specializes in medical, laser, and surgical treatment of glaucoma with a focus on minimally invasive glaucoma surgery (MIGS) and new glaucoma surgical devices. He also performs both routine and complex cataract surgery. Dr. Yohannan also specializes in the surgical management of complex problems of the anterior segment (front of the eye). These problems include issues that arise after trauma or prior surgery gone wrong such as dislocated intraocular lenses (IOL) or iris and pupil defects.

    Dr. Yohannan earned his bachelor’s degree from New York University where he graduated summa cum laude. He then received his medical and master of public health degrees from Johns Hopkins University and completed an ophthalmology residency at the Wilmer Eye Institute, Johns Hopkins University School of Medicine. From there, he served as a fellow in glaucoma and advanced anterior segment surgery at the University of Toronto with Ike Ahmed.
        
    Dr. Yohannan's research focuses on using artificial intelligence algorithms to improve the tests that are used to diagnose and monitor glaucoma. He has a background in biostatistics, epidemiology, and mathematics which enables this effort. The ultimate goal of this research is to detect glaucoma and determine when it is worsening more accurately. The results of this work will ultimately help guide doctors who are managing glaucoma to make better treatment decisions.

    Dr. Yohannan also has a clinical and research interest in novel surgical devices used to treat glaucoma. These devices hold the promise of making glaucoma surgery safer and easier to recover from.

Education & Training

  • University of Toronto
    University of TorontoFellowship, 2017 - 2018
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Ophthalmology, 2014 - 2017
  • Johns Hopkins University/Bayview Medical Center
    Johns Hopkins University/Bayview Medical CenterResidency, Internal Medicine, 2013 - 2014
  • Johns Hopkins Bloomberg School of Public Health
    Johns Hopkins Bloomberg School of Public HealthMPH, Biostatistics/Epidemiology, 2012 - 2013
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 2013, MD
  • New York University
    New York UniversityBA, Biochemistry, minors in Mathematics and Pre-business studies, Summa Cum Laude, 2008

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2018 - 2025
  • American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • Coulson Award for House staff Johns Hopkins Medicine, 2017
  • Mitchell Prize for Resident ReseOarch Wilmer Eye Institute, 2017
  • Delta Omega Public Health Honors Society Johns Hopkins University, 2012
  • Join now to see all

Publications & Presentations

PubMed

Books/Book Chapters

Abstracts/Posters

  • Intermediate outcomes of iStent or iStent Inject in Combination with Phacoemulsification
    Yohannan J, Canadian Ophthalmic Society, 1/1/2018
  • Intermediate outcomes of iStent or iStent Inject in Combination with Phacoemulsification
    Yohannan J, AGS, 1/1/2018
  • When and How Should Extrafoveal Choroidal Neovascular Lesions Be Treated? An Analysis of Data from the Macular Photocoagulatoin Study.
    Yohannan J, ARVO, 1/1/2018
  • Join now to see all

Lectures

  • Intermediate term outcomes of SIBS microshunt alone or in combination with phacoemulsification 
    1/1/2018
  • The Houdini Cataract 
    1/1/2018
  • Anterior Vitrectomy Surgical Training Course 
    1/1/2018
  • Join now to see all

Professional Memberships